1. Racial differences in response rates to consensus interferon in HCV infected patients naïve to previous therapy;Gaglio;J Clin Gastroenterol 38(7),2004
2. Njoya O, Essomba N, Essi MJ, Kowo M, Luma H, et al. (2015) Therapeutic Response to Pegylated Interferon α-2a and Ribavirin in Genotype 4 Chronic Hepatitis C in Sub Saharan Africans. JSM Gastroenterol Hepatol 3(2): 1041.
3. Njoya O, Ntsama L, Essi MJ, Kowo M, Luma H, Tzeuton C, et al. (2014) Therapeutic Response of Black Africans in the Treatment of Genotype 2 Chronic Viral Hepatitis c by Pegylated Interferon-ribavirin. Austin J Gastroenterol 1(2): 1009.
4. Nkuize Nkuize M, Mulkay JP, Adler M, Lasser L, Michielsen P, et al. ( 2013) Response of Black African patients with chronic hepatitis C virus genoytype 4 to treatment with peg-interferon an ribavirin. Acta Gastroenterol Belg 76(3): 291-299.
5. Safety and efficacy of combination therapy with peginterferon alfa-2a (40-kd) and ribavirin in the outpatient setting: Prospective analysis of 197 patients with chronic hepatitis c viral infection;Fontanges T Beorchia;Gastroenterol Clin Biol 31(6-7),2007